Open AccessEfficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis
Author(s) -
Caitriona Ryan,
Alan Menter,
Lyn Guenther,
Andrew Blauvelt,
Robert Bissonnette,
Fan Yang,
Allison P Bleakman,
David A. Amato
Publication year - 2018
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.8
Subject(s) - ixekizumab , medicine , psoriasis , placebo , dermatology , double blinded , clinical trial , randomized controlled trial , psoriatic arthritis , secukinumab , alternative medicine , pathology
not Available. Disclosures: Study sponsored by Eli Lilly. Copyright 2018 SKIN